NEW YORK, NY / ACCESS Newswire / April 7, 2025 / If you suffered a loss on your Zynex, Inc. (NASDAQ:ZYXI) investment and want to learn about a ...

New York, New York-- (Newsfile Corp. - April 7, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Zynex, Inc. (NASDAQ: ZYXI) between March 13, 2023 ...

The truth allegedly emerged on March 11, 2025, when Zynex reported its dismal Q4 and FY 2024 financial results. The complaint highlights Zynex CEO Thomas Sandgaard's attributing the fourth-quarter ...

The art and science of stock market investing requires a tolerance for losing money on some of the shares you buy.

SAN FRANCISCO, April 03, 2025 (GLOBE NEWSWIRE) -- Shares of Zynex Inc. (NASDAQ: ZYXI), a medical device manufacturer specializing in nerve stimulation products, are trading down 65% over the past ...

Zynex, Inc. (ZYXI) Securities Class Action: The litigation is focused on the propriety of Zynex's statements about its sales and billing practices, its revenue recognition practices, and its ...

A securities class action has been filed against Zynex, Inc. , a medical device manufacturer that produces and markets electrotherapy devices for use in pain management and physical ...

The Gross Law Firm issues the following notice to shareholders of Zynex, Inc. . Shareholders who purchased shares of ZYXI during ...

Segmentation Analysis Highlighted with 87 tables and 97 figures, this 210-page report represents a 360-degree view on the global market with extensively detailed segmentations by Offering, Equipment ...